María Á. S.
- Country
- Spain
- Department
- Servicio de Neurología
Research Overview
- Efficacy and Safety of Donepezil Hydrochloride in Mild Cognitive Impairment Associated with Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Candesartan Cilexetil Versus Placebo in Asymptomatic Genetic Carriers of Dilated Cardiomyopathy-Causing Variants
- Efficacy and Safety Evaluation of TX000045 in Pulmonary Hypertension Secondary to Heart Failure with Preserved Ejection Fraction: A Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 29 of 157 partner sites.
Specializations
Parkinson’s disease and movement disorders
Clinical research interests include Parkinson’s disease, multiple system atrophy, and symptom control in movement disorders, with attention to motor fluctuations, fatigue, cognition, and functional outcomes.
- Parkinson’s disease
- Multiple system atrophy
- Cognitive impairment
- Fatigue
The therapeutic profile also extends to motor symptom management and neurodegenerative disease care.
Neuroimmunology and autoimmune neuromuscular disease
Work in autoimmune neurology includes generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and other immune-mediated neurological disorders requiring targeted treatment strategies.
- Generalized myasthenia gravis
- Chronic inflammatory demyelinating polyneuropathy
- Immune thrombocytopenia
- Systemic lupus erythematosus
Therapeutic interest also covers autoantibody-associated disease and immune dysregulation.
Stroke, vascular neurology, and cardiovascular risk
Clinical activity is strongly linked to acute ischemic stroke, transient ischemic attack, and broader vascular risk reduction in patients with atherosclerotic cardiovascular disease and related cardiometabolic conditions.
- Acute ischemic stroke
- Transient ischemic attack
- Atrial fibrillation
- Atherosclerotic cardiovascular disease
Areas of interest include secondary prevention, antithrombotic therapy, and cardio-neurological comorbidity.
Neuropsychiatry and cognitive disorders
Research involvement includes schizophrenia, Alzheimer’s disease, and other conditions affecting cognition, behavior, and daily functioning.
- Schizophrenia
- Alzheimer’s disease
- Cognitive impairment
- Agitation
Therapeutic focus includes neurocognitive symptoms and behavioral disturbance.
Headache, neuropathic, and functional neurological symptoms
Additional clinical interests span migraine, neuropathic disorders, and symptom-directed care in conditions such as spasticity and pain syndromes.
- Migraine
- Polyneuropathy
- Spasticity
- Pain
These interests reflect engagement with symptom relief and neurological rehabilitation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.